BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11756238)

  • 1. Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: stereoselective metabolism and tissue distribution.
    Wu Z; Upadhyaya P; Carmella SG; Hecht SS; Zimmerman CL
    Carcinogenesis; 2002 Jan; 23(1):171-9. PubMed ID: 11756238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Zimmerman CL; Wu Z; Upadhyaya P; Hecht SS
    Carcinogenesis; 2004 Jul; 25(7):1237-42. PubMed ID: 14988218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Lao Y; Yu N; Kassie F; Villalta PW; Hecht SS
    Chem Res Toxicol; 2007 Feb; 20(2):235-45. PubMed ID: 17305407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats.
    Leslie EM; Ghibellini G; Nezasa K; Brouwer KL
    Carcinogenesis; 2007 Dec; 28(12):2650-6. PubMed ID: 17724374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.
    Upadhyaya P; Kenney PM; Hochalter JB; Wang M; Hecht SS
    Carcinogenesis; 1999 Aug; 20(8):1577-82. PubMed ID: 10426810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the rat.
    Schulze J; Richter E; Binder U; Zwickenpflug W
    Carcinogenesis; 1992 Nov; 13(11):1961-5. PubMed ID: 1423863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Zhang S; Wang M; Villalta PW; Lindgren BR; Upadhyaya P; Lao Y; Hecht SS
    Chem Res Toxicol; 2009 May; 22(5):926-36. PubMed ID: 19358518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of pyridylhydroxybutyl-DNA adducts in liver and lung of F-344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Upadhyaya P; Kalscheuer S; Hochalter JB; Villalta PW; Hecht SS
    Chem Res Toxicol; 2008 Jul; 21(7):1468-76. PubMed ID: 18570389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl DNA Phosphate Adduct Formation in Rats Treated Chronically with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Ma B; Zarth AT; Carlson ES; Villalta PW; Upadhyaya P; Stepanov I; Hecht SS
    Chem Res Toxicol; 2018 Jan; 31(1):48-57. PubMed ID: 29131934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues.
    Upadhyaya P; Carmella SG; Guengerich FP; Hecht SS
    Carcinogenesis; 2000 Jun; 21(6):1233-8. PubMed ID: 10837015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of precision-cut tissue slices in organ culture to study metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by hamster lung, liver and kidney.
    Richter E; Friesenegger S; Engl J; Tricker AR
    Toxicology; 2000 Apr; 144(1-3):83-91. PubMed ID: 10781874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver.
    Breyer-Pfaff U; Martin HJ; Ernst M; Maser E
    Drug Metab Dispos; 2004 Sep; 32(9):915-22. PubMed ID: 15319331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine.
    Carmella SG; Ye M; Upadhyaya P; Hecht SS
    Cancer Res; 1999 Aug; 59(15):3602-5. PubMed ID: 10446969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.
    Balbo S; Johnson CS; Kovi RC; James-Yi SA; O'Sullivan MG; Wang M; Le CT; Khariwala SS; Upadhyaya P; Hecht SS
    Carcinogenesis; 2014 Dec; 35(12):2798-806. PubMed ID: 25269804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK) in rhesus monkeys.
    Meger M; Richter E; Zwickenpflug W; Oehlmann C; Hargaden MB; A-Rahim YI; Vesell ES
    Drug Metab Dispos; 1999 Apr; 27(4):471-8. PubMed ID: 10101142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver.
    Schrader E; Hirsch-Ernst KI; Richter E; Foth H
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):336-43. PubMed ID: 9550307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of a glucuronide conjugate of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats.
    Atawodi SE; Michelsen K; Richter E
    Arch Toxicol; 1994; 69(1):14-7. PubMed ID: 7717849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long term dietary phenethyl isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats.
    Staretz ME; Koenig LA; Hecht SS
    Carcinogenesis; 1997 Sep; 18(9):1715-22. PubMed ID: 9328166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA adducts in the lung and liver of F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and (S)-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Stepanov I; Hecht SS
    Chem Res Toxicol; 2009 Feb; 22(2):406-14. PubMed ID: 19166332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.